Abstract | PURPOSE: TXA9, a novel cardiac glycoside, has a potent anti-proliferative effect against A549 human lung cancer cells, however, possesses a poor water-solubility and a rapid metabolic rate in vivo which limited the further development of TXA9. To overcome the shortcomings of TXA9, four polymer prodrugs of TXA9 were designed and synthesized. METHODS: RESULTS: The water-solubility of TXA9 was obviously increased and prodrugs with glycine linkers showed a better stability in rat plasma. Their pharmacokinetic investigation found that the t1/2 and AUC0-∞ of TPGS-Gly-TXA9 was increased by 80- and 9.6-fold compared with that of TXA9, which was more superior than the other three prodrugs. More importantly, the tumor inhibition rate of TPGS-Gly-TXA9 (43.81%) on A549 xenograft nude mice was significantly increased compared with that of TXA9 (25.26%). CONCLUSION: The above results suggested that TPGS-Gly-TXA9 possessed better antitumor efficiency than TXA9 and could be further investigated as an anti- cancer agent.
|
Authors | Yiwen Li, Chun Ye, Chengcheng Cai, Meng Zhao, Na Han, Zhihui Liu, Jianxiu Zhai, Jun Yin |
Journal | Pharmaceutical research
(Pharm Res)
Vol. 37
Issue 3
Pg. 66
(Mar 12 2020)
ISSN: 1573-904X [Electronic] United States |
PMID | 32166420
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Cardiac Glycosides
- Polymers
- Prodrugs
- Water
|
Topics |
- A549 Cells
- Animals
- Antineoplastic Agents
(chemistry, pharmacokinetics, pharmacology, therapeutic use)
- Cardiac Glycosides
(chemistry, pharmacokinetics, pharmacology, therapeutic use)
- Drug Design
- Esterification
- Humans
- Lung Neoplasms
(drug therapy)
- Mice, Inbred BALB C
- Mice, Nude
- Polymers
(chemistry, pharmacokinetics, pharmacology, therapeutic use)
- Prodrugs
(chemistry, pharmacokinetics, pharmacology, therapeutic use)
- Rats, Sprague-Dawley
- Solubility
- Water
(chemistry)
|